Article
Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations.
The Journal of antimicrobial chemotherapy - 1 Sept 2005
Mamelli Laurent, Prouzet-Mauléon Valérie, Pagès Jean-Marie, Mégraud Francis, Bolla Jean-Michel
Abstract excerpt
BACKGROUND: Erythromycin is the drug of choice to treat human campylobacteriosis. Campylobacter isolates exhibit two different phenotypes with regard to erythromycin resistance: high-level resistant strains (HLR) and low-level resistant strains (LLR). OBJECTIVES: To study the mechanisms of resistance of Campylobacter to erythromycin, its 6-O-methyl derivative clarithromycin and the ketolide telithromycin....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
